LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Oligodendroglioma
Clinical Presentation, Pathology, Molecular Biology, Imaging, and Treatment
- 1st Edition - June 18, 2019
- Editors: Nina A. Paleologos, Herbert B. Newton
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 1 3 1 5 8 - 9
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 3 1 5 9 - 6
Oligodendroglioma: Clinical Presentation, Pathology, Molecular Biology, Imaging, and Treatment features the latest "cutting-edge" molecular biology, molecular therapeut… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteOligodendroglioma: Clinical Presentation, Pathology, Molecular Biology, Imaging, and Treatment features the latest "cutting-edge" molecular biology, molecular therapeutics, imaging, immunotherapy, and research methods on the topic of oligodendrogliomas. The most detailed and comprehensive resource on the subject, it provides up-to-date information on clinical presentation, pathology, molecular biology, and treatment methods, including immunotherapy. This book is a critical for students, physicians and researchers in the fields of neuroscience, neuro-oncology, neurosurgery, radiation oncology, medical oncology, and others working in research or with patients.
- Provides the most up-to-date information regarding the clinical presentation, pathology, molecular biology, and methods for the treatment of oligodendroglioma brain tumors, including surgical therapy, radiotherapy, molecular therapeutics, chemotherapy, and immunotherapy
- Broadly appeals to anyone interested in the field of neuro-oncology and the treatment of patients with oligodendrogliomas
- Useful to clinicians interested in a thorough overview of the basic science and treatment of oligodendrogliomas
- Includes a section on immunotherapy, with updates on the use of vaccines and immune-based treatment approaches applied to oligodendrogliomas
Neuroscientists, neurobiologists, neuro-oncologists, neurologists, post-doctoral fellows, researchers, graduate students in biological and biomedical sciences
SECTION I. CLINICAL PRESENTATION AND QUALITY OF LIFE1. Clinical Presentation in Adults - Brain2. Clinical Presentation of Spinal Oligodendrogliomas3. Oligodendrogliomas – Atypical Clinical Presentations4. Clinical Presentation of Pediatric Oligodendrogliomas5. Seizures & Oligo’s6. Living with Oligodendroglioma
SECTION II. PATHOLOGY AND MOLECULAR BIOLOGY7. Origin and Development of Oligodendroglioma8. Pathology and Molecular Biology Oligo’s9. The role of biomarkers in the diagnosis and treatment of oligodendrogliomas10. Prospects of translational proteomics and protein microarrays in oligodendroglioma11. Pathology of Pediatric Oligodendroglioma
SECTION III. NEURO-IMAGING 12. CT Imaging of Oligodendroglioma13. Routine and Advanced Magnetic Resonance Imaging of Oligodendrogliomas14. Advanced [11C]Methionine and [18F]FDG Positron Emission Tomography for Diagnosis, Treatment, and Follow Up of Oligodendrogliomas15. Neuroimaging of Pediatric Oligodendrogliomas
SECTION IV. SURGICAL THERAPY16. Oligodendrogliomas: Basic Techniques in Surgery17. Oligodendrogliomas: Advanced Techniques in Surgery18. Surgical management of 1p/19q co-deleted oligodendrogliomas WHO grade II and III19. Surgical Results in Anaplastic Oligodendroglioma (AO) and Anaplastic Oligoastrocytoma (AOA)20. Surgical Management of Pediatric Oligodendroglioma
SECTION V. RADIATION THERAPY 21. Basic Principles of Brain Tumor Radiotherapy22. Standard External Beam Radiation Therapy for Oligodendroglioma23. Stereotactic Radiosurgery in the management of Oligodendroglioma24. Proton Beam Therapy for Oligodendroglioma 25. Interstitial Brachytherapy treatment for Oligodendrogliomas26. The Role of Radiation in Pediatric Oligodendrogliomas
SECTION VI. CHEMOTHERAPY AND IMMUNOTHERAPY27. Basic Principles of Brain Tumor Chemotherapy28. The use of PCV Chemotherapy in Oligodendrogliomas29. Temozolomide Chemotherapy for Oligodendroglial Tumors30. Miscellaneous Chemotherapy Approaches to Oligodendroglial Tumors31. Molecular Therapy for Oligodendrogliomas32. Bevacizumab for Recurrent Anaplastic Oligodendroglial Tumors33. Pediatric Oligodendroglioma34. Immune Checkpoint Blockade in Glioma
- No. of pages: 422
- Language: English
- Edition: 1
- Published: June 18, 2019
- Imprint: Academic Press
- Hardback ISBN: 9780128131589
- eBook ISBN: 9780128131596
NP
Nina A. Paleologos
Dr. Paleologos is currently Director of Neuro Oncology and Director of Neurology for Advocate Medical Group, the largest physician group in Illinois, with Advocate Healthcare including 12 Hospitals in Illinois. Advocate Healthcare is also part of Advocate Aurora Health. She is also Professor (Adjunct) of Neurological Sciences, Rush University Medical School in Chicago, IL. She has published over 60 journal articles and book chapters in the fields of Neuro-Oncology and Neurology. She has been named as a Best Doctor’s in America (2005-2019) and as a Top Doctor in Chicago in Neurology for several years. She was one of two neuro oncologists named as Chicago Magazine's best neuro oncologists in Chicago and received a Career Acheivement Award from the Chicago Neurological Society for "exceptional expertise, knowledge, dedication and recognition in the field of Neuro-Oncology" in 2013. She has been Chair of the Section of Neurology for the American Academy of Neurology, and is Chairman of the Neuro Oncology Exam Committee for the United Council of Neurological Subspecialities.
Affiliations and expertise
Director of Neuro-Oncology and Medical Director of Neurology, Advocate Medical Group, Advocate Healthcare; Professor (Adjunct) of Neurological Sciences, Rush University Medical School, Chicago, IL, USAHN
Herbert B. Newton
Dr. Newton is currently the Director of the Neuro-Oncology Center and CNS Oncology Program at the Advent Health Cancer Institute and Advent Health Orlando Campus. He recently retired as Professor of Neurology and Neurosurgery at the Ohio State University Medical Center and the James Cancer Hospital, and was the holder of the Esther Dardinger Endowed Chair in Neuro-Oncology. He trained in Neuro-Oncology with Drs. Jerome Posner and William Shapiro at Memorial Sloan-Kettering Cancer Center in New York, and since then had been in academic Neuro-Oncology for over 25 years. He has published more than 220 peer-reviewed articles and book chapters, and is the Chief Editor or Co-Editor of ten textbooks in the field of Neurology and Neuro-Oncology. In addition, he has been listed as a Best Doctor (Neurology) and Top Doctor for Cancer (Neuro-Oncology) for the past 18 years.
Affiliations and expertise
Advent Health Cancer Institute, FL, USARead Oligodendroglioma on ScienceDirect